Quest Diagnostics

Forecast & Rating17 analysts currently cover Quest Diagnostics, with about 52.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $245.87, about 4.2% upside from the current price of $236.04. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 90.8% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Quest Diagnostics are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Aug 3, 2026; for reference only and not investment advice.